CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US18914F1030
CLOVER HEALTH INVESTMENTS, CORP. /DE financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.92 bn USD |
| Operating income | -85.53 m USD |
| EBIT | -85.55 m USD |
| Net income | -85.55 m USD |
| Diluted EPS – continuing operations | -0.17 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CLOVER HEALTH INVESTMENTS, CORP. /DE
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
More stocks
- Fidelity European Trust PLC (FEV.L)
- Hainan Mining Co Ltd (601969.SS)
- Sunstone Hotel Investors, Inc. (SHO)
- NBTM New Materials Group Co Ltd (600114.SS)
- Chung-Hsin Electric & Machinery Mfg Corp (1513.TW)
- CECEP Solar Energy Co Ltd (000591.SZ)
- PITNEY BOWES INC /DE/ (PBI)
- CPI Europe AG (CPI.VI)
- Premier Foods PLC (PFD.L)
- Zhejiang JIULI Hi-tech Metals Co Ltd (002318.SZ)
- Lakala Payment Co Ltd (300773.SZ)
- Celldex Therapeutics, Inc. (CLDX)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.